Liminal BioSciences to Voluntarily Delist from the Toronto Stock Exchange
- Wednesday, July 22, 2020, 7:03
- Finance
- Add a comment
LAVAL, QC and CAMBRIDGE, England, July 22, 2020 /PRNewswire/ – Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company, announces that it has applied for a voluntarily delisting of its common shares (“Common…
About the Author
adminasapcorp has written 41828 stories on this site.